Use the keywords feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
November 14, 2022: Medical Letter on Drugs and Therapeutics
#2
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
November 16, 2020: Medical Letter on Drugs and Therapeutics
#3
JOURNAL ARTICLE
Tomáš Edelsberger
Fixed dose combination of two different drugs in the same or related indications are successfully used in various medical fields including diabetology. This article deals with the combination therapy comprising metformin and dapagliflozin in a single preparation, molecules affecting different pathophysiological mechanisms of type 2 diabetes, particularly insulin resistance and increased glucose reabsorption in the kidney. Most patients with type 2 diabetes does not achieve target glycemic control when treated with single antidiabetics and need for proper control of diabetes combination of several different drugs...
March 2016: Vnitr̆ní Lékar̆ství
#4
JOURNAL ARTICLE
Qin C Ji, Xiaohui Xu, Eric Ma, Jane Liu, Shenita Basdeo, Guowen Liu, William Mylott, David W Boulton, Jim X Shen, Bruce Stouffer, Anne-Françoise Aubry, Mark E Arnold
Dapagliflozin (Farxiga), alone, or in the fixed dose combination with metformin (Xigduo), is an orally active, highly selective, reversible inhibitor of sodium-glucose cotransporter type 2 (SGLT2) that is marketed in United States, Europe, and many other countries for the treatment of type 2 diabetes mellitus. Here we report a liquid chromatography-tandem mass spectrometry (LC-MS/MS) bioanalytical assay of dapagliflozin in human plasma. A lower limit of quantitation (LLOQ) at 0.2 ng/mL with 50 μL of plasma was obtained, which reflects a 5-fold improvement of the overall assay sensitivity in comparison to the previous most sensitive assay using the same mass spectrometry instrumentation...
March 17, 2015: Analytical Chemistry
#5
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
February 10, 2015: JAMA
#6
REVIEW
(no author information available yet)
No abstract text is available yet for this article.
2014: Medical Letter on Drugs and Therapeutics
1
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
